derivado de triazina e composição farmacêutica compreendendo o mesmo

The present invention provides a novel P2X 3 and/or P2X 2 / 3 receptor antago nist. A compound represented by the formula (I): wherein R a , R b and R c are, (a) R a and R b are taken together =Z; and R c is a group represented by R 1c ; or (b) R b and R c are taken together to form a bond; and R a...

Full description

Saved in:
Bibliographic Details
Main Authors MIHO OOHARA, TAKAYUKI KAMEYAMA, TAKESHI ENDOH, TSUYOSHI HASEGAWA, YUKIO TADA, HIROYUKI KAI
Format Patent
LanguagePortuguese
Published 19.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a novel P2X 3 and/or P2X 2 / 3 receptor antago nist. A compound represented by the formula (I): wherein R a , R b and R c are, (a) R a and R b are taken together =Z; and R c is a group represented by R 1c ; or (b) R b and R c are taken together to form a bond; and R a is a group represented by -Y-R 1a ; R 1a and R 1c are each independently hydrogen, substituted or unsubstituted alkyl, etc.; R 2 and R 3 are each independently substituted or unsubstituted aryl, etc.; R 4a and R 4b are each independently hydrogen, substituted or unsubstituted alkyl, etc.; X is -N(R 5 )-, etc.; R 5 is hydrogen, substituted or unsubstituted lower alkyl, etc.; -Y- is -O-, etc.; =Z is =O, etc.; and n is an integer of 0 to 4.
Bibliography:Application Number: BR2010PI13642